| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |